Asset Management One Co. Ltd. lessened its stake in The Sherwin-Williams Company (NYSE:SHW – Free Report) by 4.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 114,602 shares of the specialty chemicals company’s stock after selling 5,440 shares during the period. Asset Management One Co. Ltd.’s holdings in Sherwin-Williams were worth $43,740,000 at the end of the most recent reporting period.
Several other hedge funds have also made changes to their positions in SHW. Tamar Securities LLC lifted its stake in Sherwin-Williams by 3.4% during the third quarter. Tamar Securities LLC now owns 48,753 shares of the specialty chemicals company’s stock worth $18,608,000 after purchasing an additional 1,604 shares during the period. Valeo Financial Advisors LLC lifted its stake in Sherwin-Williams by 7.9% during the second quarter. Valeo Financial Advisors LLC now owns 2,636 shares of the specialty chemicals company’s stock worth $787,000 after purchasing an additional 193 shares during the period. Transcend Capital Advisors LLC lifted its stake in Sherwin-Williams by 24.1% during the second quarter. Transcend Capital Advisors LLC now owns 7,805 shares of the specialty chemicals company’s stock worth $2,329,000 after purchasing an additional 1,514 shares during the period. Handelsbanken Fonder AB lifted its stake in Sherwin-Williams by 4.3% during the third quarter. Handelsbanken Fonder AB now owns 98,118 shares of the specialty chemicals company’s stock worth $37,449,000 after purchasing an additional 4,074 shares during the period. Finally, BI Asset Management Fondsmaeglerselskab A S lifted its stake in Sherwin-Williams by 17.3% during the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 20,592 shares of the specialty chemicals company’s stock worth $7,152,000 after purchasing an additional 3,031 shares during the period. Institutional investors own 77.67% of the company’s stock.
Analyst Ratings Changes
A number of research analysts have recently issued reports on the stock. Redburn Atlantic upgraded shares of Sherwin-Williams to a “strong-buy” rating in a research note on Thursday, July 18th. Barclays lifted their target price on shares of Sherwin-Williams from $355.00 to $370.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 23rd. Citigroup cut their target price on shares of Sherwin-Williams from $430.00 to $420.00 and set a “buy” rating for the company in a research note on Thursday, October 24th. The Goldman Sachs Group lifted their target price on shares of Sherwin-Williams from $344.00 to $390.00 and gave the company a “buy” rating in a research note on Wednesday, July 24th. Finally, Wells Fargo & Company raised their price target on shares of Sherwin-Williams from $350.00 to $400.00 and gave the company an “equal weight” rating in a report on Tuesday, October 15th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Sherwin-Williams presently has a consensus rating of “Moderate Buy” and a consensus price target of $395.29.
Insider Activity
In other news, CFO Allen J. Mistysyn sold 14,520 shares of the business’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $366.83, for a total value of $5,326,371.60. Following the completion of the transaction, the chief financial officer now owns 63,520 shares of the company’s stock, valued at $23,301,041.60. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.60% of the stock is owned by company insiders.
Sherwin-Williams Price Performance
SHW opened at $374.40 on Tuesday. The company has a fifty day moving average price of $372.64 and a two-hundred day moving average price of $337.22. The company has a debt-to-equity ratio of 1.97, a quick ratio of 0.51 and a current ratio of 0.83. The Sherwin-Williams Company has a 52 week low of $249.49 and a 52 week high of $392.57. The firm has a market capitalization of $94.29 billion, a PE ratio of 37.29, a P/E/G ratio of 2.88 and a beta of 1.17.
Sherwin-Williams (NYSE:SHW – Get Free Report) last announced its quarterly earnings results on Tuesday, October 22nd. The specialty chemicals company reported $3.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.56 by ($0.19). Sherwin-Williams had a net margin of 11.09% and a return on equity of 74.45%. The firm had revenue of $6.16 billion during the quarter, compared to analyst estimates of $6.20 billion. During the same period last year, the firm earned $3.20 EPS. Sherwin-Williams’s quarterly revenue was up .7% on a year-over-year basis. As a group, analysts anticipate that The Sherwin-Williams Company will post 11.32 earnings per share for the current year.
Sherwin-Williams Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be issued a $0.715 dividend. This represents a $2.86 annualized dividend and a dividend yield of 0.76%. The ex-dividend date is Friday, November 15th. Sherwin-Williams’s dividend payout ratio (DPR) is 28.49%.
Sherwin-Williams Company Profile
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Featured Articles
- Five stocks we like better than Sherwin-Williams
- 3 Best Fintech Stocks for a Portfolio Boost
- Intel: Is Now the Time to Be Brave?Â
- Best Aerospace Stocks Investing
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Want to see what other hedge funds are holding SHW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Sherwin-Williams Company (NYSE:SHW – Free Report).
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.